NguyenTVDamianiGOrensteinLVHamzaviIJemecGB. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol. 2021;35(1):50-61. doi:10.1111/jdv.16677
2.
BouadiNRijalHJeremianR, et al. Comorbidities and risk factors associated with hidradenitis suppurativa: a systematic review and meta-analysis. J Cutan Med Surg. 2024;28(4):392-393. doi:10.1177/12034754241239252
3.
RachedNARüthJGambichlerTOckerLBecharaFG. A state-of-the-art systematic review of cancer in hidradenitis suppurativa. Ann Med. 2024;56(1):2382372. doi:10.1080/07853890.2024.2382372
4.
GauSYHsiaoYPLiaoWCMaKSKWuMC. Risk of liver dysfunction and non-alcoholic fatty liver diseases in people with hidradenitis suppurativa: a systematic review and meta-analysis of real-world evidences. Front Immunol. 2022;13:959691. doi:10.3389/fimmu.2022.959691
5.
GauSArniIJames Cheng-ChungWeiLeeCYKuanYHHsiaoYP, et al. Risk of psoriasis in people with hidradenitis suppurativa: A systematic review and meta-analysis. Front Immunol. 2022;13:1033844. doi:10.3389/fimmu.2022.1033844
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.